Join today and have your say! It’s FREE!

We will not release or resell your information to third parties without your permission.

Please Try Again

{{ error }}

By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Please Try Again

{{ error }}

Password Hint : {{passwordHint}}

Remember me

Forgot Password?

or

Privacy Policy | Disclaimer

Quote | Bullboard | News | Opinion | Profile | Peers | Filings | Financials | Options | Price History | Ratios | Ownership | Insiders | Valuation

Bullboard - Stock Discussion Forum Altamira Therapeutics Ltd CYTOF

Healthcare Biotechnology

Altamira Therapeutics Ltd. is a Bermuda-based company engaged in developing ribonucleic acid (RNA)-based therapeutics for extrahepatic targets (OligoPhore/SemaPhore delivery platforms). The Company has two flagship short interfering (siRNA) programs in preclinical development beyond in vivo proof of concept: AM-401 for KRAS driven cancer and AM-411 for rheumatoid arthritis. The delivery... see more

Add To Watchlist

Bullboard (OTCQB:CYTOF)

View:

Comment by Iseneschalon Feb 02, 2024 11:56am

RE:RE:CYTO....All u get is a 20 : 1 "haircut".......then the

Well well well............ Mr. Maggot is putting "the screws" to all the Retail Spear-catchers ; ) Ya just never know when the tide will change GLTA... $1.73 now

24

Discussion

Comment by Iseneschalon Jan 31, 2024 3:01pm

RE:CYTO....All u get is a 20 : 1 "haircut".......then the

As Previously mentioned........Not only did th RS sh holders get a haircut....they got their Balls shaved also 10 cent pre-split paper........what a train wreck Anyone interested ????

49

Discussion

RVV Provides Update on Research Study Evaluating Bucillamine for Nerve Agent Exposure

posted Jan 09, 2025 9:00am by Revive Therapeutics Ltd

Over the next few weeks data will be collected and analysed for effect size. Should the data show significant effects, Revive and the DRDC will discuss on the future development path. The results from this research study, if promising, will determine further studies to facilitate FDA and Health Canada approvals for the use of Bucillamine in nerve agents or organophosphate pesticide poisoning and explore its potential for traumatic brain injury caused by concussive or explosive forces and viral infections. ...read more

Post by Iseneschalon Jan 29, 2024 2:39pm

CYTO....stay tuned for some Price Action...JMHO

Looks like Mr. M is getting all his "Ducks" in order Start the drumroll...currently at $1.94 bid....offered at $2.02

83

Discussion

Post by Iseneschalon Jan 24, 2024 11:45am

CYTO...no wonder there was a little pop & vol ; )

Altamira Therapeutics to Present at 3rd Annual mRNA-Based Therapeutics Summit 2024-01-08 05:47 ET - News Release HAMILTON, BERMUDA , Jan. 08, 2024 (GLOBE NEWSWIRE ...more

45

Post by PressReleaseon Jan 08, 2024 8:47am

New Press Release - Altamira Therapeutics to Present at 3rd Annual mRNA-Based Therapeutics Summit

HAMILTON, BERMUDA , Jan. 08, 2024 (GLOBE NEWSWIRE) -- Altamira Therapeutics to Present at 3rd Annual mRNA-Based Therapeutics SummitAltamira’s two flagship programs, AM-401 and AM-411, designed for KRAS-driven cancer and rheumatoid arthritis, serve to demonstrate the technology’s capability to...read article.

Post by PressReleaseon Dec 29, 2023 8:47am

New Press Release - Altamira Therapeutics Regains Compliance with Nasdaq Minimum Bid Price Requirement

HAMILTON, BERMUDA, Dec. 29, 2023 (GLOBE NEWSWIRE) -- HAMILTON, BERMUDA, Dec. 29, 2023 -- Altamira Therapeutics Ltd. ("Altamira" or the "Company") (Nasdaq: CYTO), a company providing nanoparticle-based technology for efficient RNA delivery to extrahepatic targets, announced that it received a...read article.

Post by Iseneschalon Dec 21, 2023 3:31pm

CYTO.....Frontloaders offing the cheap stuff ; )

Don't be a bagholder

46

Post by Iseneschalon Dec 21, 2023 2:08pm

CYTO....All u get is a 20 : 1 "haircut".......then the

" Tomahawk chop"......N.L.O.D Get used to it There is nothing good about this Train wreck

75

Discussion

Post by Iseneschalon Dec 13, 2023 11:12am

CYTO....hurry up and dye !

JMHO

41

Post by Iseneschalon Dec 13, 2023 10:24am

CYTO.....case in point LoL

Now in PB mode right after N.H.O.D Up on low volume ....down on lower volume

39

Post by Iseneschalon Dec 13, 2023 10:21am

CYTO..... pick ur spot LoL

This could be sub $4 or north of $10 in a heartbeat Too risky for me

57

Post by Iseneschalon Dec 13, 2023 10:09am

CYTO....RS eff this a.m....very tight float

350,000 shs o/s No position....unfortunately ; )

46

Post by PressReleaseon Dec 11, 2023 8:00am

New Press Release - Altamira Therapeutics Provides Investor and Business Update

HAMILTON, BERMUDA, Dec. 11, 2023 (GLOBE NEWSWIRE) -- Company hosts Investor and Business Update call on December 11 at 8:30 a.m. ETPartial spin-off of Bentrio® business first step in transition to become ‘pure play’ RNA delivery companyTransition expected to complete in 2024 through partnering of...read article.

Post by Nibinatoron Dec 06, 2023 3:17pm

Aller up on remet ca

Up up up up

90

Post by Nibinatoron Dec 05, 2023 2:25pm

Boom

Live

46

The Market Update

{{currentVideo.title}} {{currentVideo.relativeTime}}

< Previous bulletin

Next bulletin >

A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}

{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}

{{currentVideo.headline}}

{{currentVideo.link1Text}}

{{currentVideo.link2Text}}

< Previous

{{moreVideoText}}

Next >

Dealroom for high-potential pre-IPO opportunities

Featured News Links

Global Tungsten Market Overview and Supply Security

LEARN about a Biotech Rising to New Heights and Transforming Regenerative Medicine